Overview

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The study will compare the efficacy and safety of brivaracetam with placebo in patients with Unverricht-Lundborg disease.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma SA
Treatments:
Brivaracetam